Hvilken er prisen på Fresh2 Group Limited (FRES)

Prisen på Fresh2 Group Limited (FRES) er $0.85

Hva er markedsverdien på Fresh2 Group Limited (FRES)

Markedsverdien på Fresh2 Group Limited (FRES) er $411.40

Fresh2 Group Limited (FRES) P/S-forhold

Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.

År	P/S-forhold	Endre
2026 (TTM)	1.17	3,795.33%
2022	0.03	-13.80%
2021	0.03	-70.24%
2020	0.10	-73.12%
2019	0.37	-0.30%
2018	0.37	-45.00%
2017	0.68	0.00%

År

P/S-forhold

Endre

2026 (TTM)

1.17

3,795.33%

2022

0.03

-13.80%

2021

0.03

-70.24%

2020

0.10

-73.12%

2019

0.37

-0.30%

2018

0.37

-45.00%

2017

0.68

0.00%

Selskap	P/S-forhold	Forskjell i P/S-forhold	Land
Vertex Pharmaceuticals Incorporated VRTX.US	9.88	745.52%	US
Argenx SE ARGX.US	10.30	781.65%	NL
Lonza Group AG LONN.SW	-	-	CH
UCB S.A. UCB.BR	4.98	326.09%	BE
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR

Selskap

P/S-forhold

Forskjell i P/S-forhold

Land